Immunic (IMUX) Operating Expenses (2013 - 2026)
Immunic (IMUX) posted Operating Expenses of $33.2 million for Q1 2026, up 42.47% sequentially from $23.3 million in Q4 2025, and up 23.9% YoY from $26.8 million in Q1 2025.
Immunic (IMUX) Operating Expenses (2013 - 2026) Analysis & Trends
Immunic has reported Operating Expenses for 14 years, with the latest figure at $33.2 million in Q1 2026.
- Quarterly Operating Expenses rose 23.9% year-over-year to $33.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $109.6 million (up 8.56% YoY) and the FY2025 annual result came in at $103.2 million, up 5.28% from the prior year.
- Operating Expenses grew to $33.2 million in Q1 2026 per IMUX's latest filing, from $23.3 million in the prior quarter.
- Over five years, Operating Expenses peaked at $57.3 million in Q4 2022 and troughed at $20.1 million in Q3 2022.
- A 5-year average of $26.7 million and a median of $25.0 million in 2023 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2023: Operating Expenses jumped 163.92% in 2022, then sank 59.21% in 2023.
- Over 5 years, Operating Expenses stood at $57.3 million in 2022, then tumbled by 59.21% to $23.4 million in 2023, then rose by 9.62% to $25.6 million in 2024, then fell by 8.99% to $23.3 million in 2025, then jumped by 42.47% to $33.2 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $33.2 million, $23.3 million, and $26.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Immunic | 682.77 Mn | 682.77 Mn | - | 35.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 35.33 Mn |
| Mar 31, 2026 | 33.24 Mn |
| Dec 31, 2025 | 23.33 Mn |
| Sep 30, 2025 | 25.99 Mn |
| Jun 30, 2025 | 27.08 Mn |
| Mar 31, 2025 | 26.83 Mn |
| Dec 31, 2024 | 25.63 Mn |
| Sep 30, 2024 | 25.73 Mn |
| Jun 30, 2024 | 22.81 Mn |
| Mar 31, 2024 | 23.88 Mn |
| Dec 31, 2023 | 23.38 Mn |
| Sep 30, 2023 | 23.57 Mn |
| Jun 30, 2023 | 25.02 Mn |
| Mar 31, 2023 | 27.25 Mn |
| Dec 31, 2022 | 57.33 Mn |
| Sep 30, 2022 | 20.12 Mn |
| Jun 30, 2022 | 20.61 Mn |
| Mar 31, 2022 | 21.44 Mn |
| Dec 31, 2021 | 21.72 Mn |
| Sep 30, 2021 | 18.39 Mn |